Press Releases about Lexaria Bioscience Corp
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
November 25, 2024
Via ACCESSWIRE
Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
November 14, 2024
Via ACCESSWIRE
Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
November 07, 2024
Via ACCESSWIRE
Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
October 09, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Lexaria Updates Current GLP-1 Market
October 08, 2024
Via ACCESSWIRE
Lexaria Appoints Michael Shankman as Chief Financial Officer
October 01, 2024
Via ACCESSWIRE
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Shares Letter from Outgoing CEO
September 06, 2024
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|